Adhesive Capsulitis (Frozen Shoulder)
Investigational adjunct in stage II frozen shoulder; small case series suggest accelerated range-of-motion recovery as add-on to physiotherapy.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- Not FDA-cleared for adhesive capsulitis (frozen shoulder). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for frozen shoulder is investigational.
- Welche Evidenz existiert?
- Tier C (investigational). Small case series describe pain and range-of-motion improvements after multiple sessions. There are no randomized controlled trials. Frozen shoulder is a self-limited condition (typical duration 12-30 months), which complicates uncontrolled outcome interpretation. Evidence-based first-line care includes physical therapy (stretching, mobilization), NSAIDs, intra-articular corticosteroid injection, hydrodilation, and — for refractory cases — manipulation under anesthesia or arthroscopic capsular release.
- Hauptrisiken
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the shoulder for 5 to 10 days
- Itching and irritation at bite sites
- Local skin infection or, rarely, Aeromonas infection
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of shoulder pain or stiffness for 1 to 2 days
- Small permanent scars at bite sites
- Wer dies nicht in Betracht ziehen sollte
- Patients on blood thinners (warfarin INR >2.0, DOACs, heparin)
- Patients with hemophilia or other bleeding disorders
- Patients with severe anemia (Hb <10 g/dL)
- Patients with poorly controlled diabetes (diabetes worsens prognosis and infection risk)
- Patients with active septic arthritis or local skin infection
- Patients who have not engaged with physical therapy
- Patients with a weakened immune system
- Was Sie Ihren Kliniker fragen sollten
- Have I been evaluated by orthopedics or sports medicine, and is the diagnosis confirmed (not impingement, rotator-cuff tear, or referred pain)?
- Am I in the freezing, frozen, or thawing phase, and what is the right treatment for each?
- Have I completed structured physical therapy, NSAIDs, and considered an intra-articular corticosteroid injection or hydrodilation?
- What evidence supports leech therapy for adhesive capsulitis specifically?
- Given my diabetes status (if applicable), how does this affect cellulitis risk?
- What is the practitioner's experience and Aeromonas-prevention plan?
- What is the cost?
- Wann dringende medizinische Versorgung suchen
- Fever, hot swollen shoulder joint (possible septic arthritis)
- New severe shoulder pain after trauma (rule out fracture or tear)
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Bleeding from a bite site lasting more than 24 to 48 hours
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
Was dies NICHT bedeutet
- This is not FDA-cleared for adhesive capsulitis.
- Frozen shoulder is self-limited (12-30 months) — uncontrolled improvements cannot be attributed to therapy.
- Mechanism rationale (local anti-inflammation) does NOT establish clinical efficacy.
- Leech therapy will NOT release adhesions or replace capsular release in refractory cases.
- Leech therapy is not a substitute for physical therapy and standard injections.
Sicherheits-Querverweise
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M75.00, M75.01, M75.02
- Safety tier
- low
Evidence Summary
Adhesive capsulitis progresses through freezing, frozen, and thawing phases over 12-24 months. Standard management includes physiotherapy, intra-articular corticosteroid injection, and hydrodistension. No controlled clinical trial or case series of leech therapy for adhesive capsulitis has been published; use is investigational and mechanistic only, with a speculative local anti-inflammatory rationale on capsular synovitis. Because the condition is largely self-limiting, any observed improvement could reflect natural disease progression rather than treatment effect.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Wani SA et al. (2019), n=20
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Recent intra-articular corticosteroid injection (<4 weeks)
- Glenohumeral joint instability or recent rotator cuff repair
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.